Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Today marks the launch of a new Oxford-wide initiative – the Oxford Centre for Haematology (OCH).

This virtual Centre aims to promote integration between academic and clinical haematology programmes in the University and Oxford University Hospitals NHS Foundation Trust and thereby capitalise on scientific opportunities to transform our understanding of haematopoiesis and blood diseases, with the goal of radically improving patient care.

The OCH will be led by Prof Paresh Vyas, a member of the MRC Molecular Haematology Unit based at the MRC WIMM, and several of the centre’s members are based at our Institute.

OCH builds on over 40 years of haematology research excellence in Oxford. From the pioneering work on globins led by our founder Professor Sir David Weatherall, Prof John Clegg and Prof Doug Higgs, through to our current position of driving the largest blood cancer clinical trials program in the UK, Oxford is truly a powerhouse of haematology research. OCH will build on, and enhance, our understanding of blood cancers, ageing of the haematopoietic system and the links with inflammation and immunity. The Centre will also raise new funding for research, trials and implementation into clinical practice, alongside training the next generation of scientists and healthcare professionalsand encouraging partnerships.

Establishing the Centre has been made possible thanks to funding from the NIHR Oxford Biomedical Research Centre and will be hosted by RDM, embedded within the Nuffield Division of Clinical Laboratory Sciences.

More information can be found here and all are invited to attend the OCH Inaugural Symposium on the 26 March.

Please direct any questions about OCH to Julie Stevens,whose desk is based in the WIMM’s Administration Office.

Similar stories

T cell Immunotherapy animation launched

A new animation explores work by the Chakraverty Group, Vyas Group, and Professor Borrow from the Jenner Institute.

New study reveals role of lymphatic system in bone healing

It was previously assumed that bones lacked lymphatic vessels, but new research from the Kusumbe Group published in Cell not only locates them within bone tissue, but demonstrates their role in bone and blood cell regeneration and reveals changes associated with aging.

Irene Roberts delivers Ham-Wasserman Lecture

Presented at the American Society of Hematology Annual Meeting, the award and lectureship recognises individuals from outside the United States who have made significant contributions to Haematology.

Anjali Kusumbe receives Women in Cell Biology Early Career Medal

Founded in 2015 to mark the 50th anniversity of the founding of the British Society for Cell Biology, the award recognises outstanding early career biologists.

Asger Jakobsen receives ASH-BSH Abstract Achievement Award

Dr Jakobsen, a Clinical Research Fellow and DPhil student from the Vyas Group has received the award from the American Society of Hematology and the British Society of Haematology.

New Studentship honours Enzo Cerundolo

A new Studentship has been announced in memory of the late MRC HIU Director and MRC WIMM Group Leader.